查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1612719

CRISPR 基因編輯市場：按產品、技術、應用和最終用途分類 - 2025-2030 年全球預測

CRISPR Gene Editing Market by Offering (Reagents & Consumables, Services, Software & Systems), Technology (Anti-CRISPR Proteins, CRISPR/Cas13, CRISPR/Cas9), Application, End-use - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年CRISPR基因編輯市值為32.5億美元，預計到2024年將達到37.7億美元，複合年成長率為16.81%，到2030年將達到96.6億美元。

CRISPR基因編輯是一項創新技術，可以精確地修改基因序列，正在徹底改變生物技術和醫學。 CRISPR 的應用範圍從農業到醫學，具有解決遺傳性疾病、增強作物抗性並促進生物技術進步的潛力。對 CRISPR 的需求源於其精確定位和編輯遺傳密碼的能力，這使其對於遺傳研究和治療開發至關重要。 CRISPR 應用包括基因治療、遺傳疾病建模、藥物發現和農業基因改造。主要最終用戶是參與基因研究和產品開發的學術機構、生技公司和製藥公司。

主要市場統計
基準年[2023] 32.5億美元
預計年份 [2024] 37.7億美元
預測年份 [2030] 96.6億美元
複合年成長率（%） 16.81%

根據市場洞察，CRISPR 市場的成長是由遺傳學和基因組學研究資金籌措的增加、CRISPR 平台的技術進步以及受諸如此類因素影響的需要創新治療方法的遺傳疾病的患病率上升推動的。商業機會比比皆是，包括擴大 CRISPR 在精準醫學中的應用、開發基於 CRISPR 的診斷和合成生物學。公司可以透過投資研究合作、加強知識產權組合以及將應用領域擴展到當前療法之外來利用這些機會。

然而，由於倫理問題、監管障礙以及與 CRISPR 修飾相關的潛在脫靶效應，市場成長面臨限制。專利格局的複雜性也為市場進入者帶來了挑戰。倫理方面的考慮需要仔細審查和對話，以確保公眾接受和監管合規，而正在進行的研究旨在提高基因編輯的特異性並減少意外突變，這就是我的目標。

創新和研究的最佳領域包括提高 CRISPR 的準確性、開發體內應用的遞送機制以及探索表觀遺傳修飾。此外，將 CRISPR 與人工智慧和巨量資料分析相結合可以為研究帶來深刻的見解和效率。市場的本質是動態且快速發展的，跨學科合作正在推動進步。為了實現永續成長，公司應專注於解決道德問題和監管途徑，同時保持對創新和公民參與的堅定承諾。

市場動態：揭示快速發展的 CRISPR 基因編輯市場的關鍵市場洞察

供需的動態交互作用正在改變 CRISPR 基因編輯市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 對遺傳疾病新疫苗和治療方法的需求不斷成長
    • 增加對生物技術和製藥領域的私人和公共投資
    • 在太空探索中採用 CRISPR 基因編輯
  • 市場限制因素
    • CRISPR療法高成本
  • 市場機會
    • CRISPR 基因編輯的進展與改進
    • CRISPR基因編輯在農業領域的可能性
  • 市場挑戰
    • CRISPR 基因編輯的技術挑戰與倫理議題

波特五力：開拓 CRISPR 基因編輯市場的策略工具

波特的五力架構是了解 CRISPR 基因編輯市場競爭格局的關鍵工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解 CRISPR 基因編輯市場的外部影響

外部宏觀環境因素在塑造 CRISPR 基因編輯市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解 CRISPR 基因編輯市場的競爭格局

對 CRISPR 基因編輯市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣CRISPR基因編輯市場供應商績效評估

FPNV定位矩陣是評估CRISPR基因編輯市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議繪製 CRISPR 基因編輯市場的成功之路

對於想要加強在全球市場的影響力的公司來說，對 CRISPR 基因編輯市場進行策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 對遺傳疾病新疫苗和治療方法的需求增加
      • 增加對生物技術和製藥領域的私人和公共投資
      • 在太空探勘中採用 CRISPR 基因編輯
    • 抑制因素
      • CRISPR療法高成本
    • 機會
      • CRISPR 基因編輯的進展與改進
      • CRISPR基因編輯在農業的潛在應用
    • 任務
      • 與 CRISPR 基因編輯相關的技術挑戰和倫理問題
  • 市場區隔分析
    • 技術：CRISPR/Cas13 在涉及 RNA 操作的應用中越來越受歡迎
    • 最終用途：CRISPR 基因編輯在製藥和生物技術公司的治療方法開發和藥物發現中日益重要
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 CRISPR 基因編輯市場：透過提供

  • 試劑/耗材
  • 服務
  • 軟體及系統

第7章 CRISPR 基因編輯市場：依技術分類

  • 抗CRISPR蛋白
  • 保鮮盒/Cas13
  • 保鮮盒/Cas9
  • CRISPR/Cpf1（Cas12a）

第8章 CRISPR 基因編輯市場：依應用分類

  • 診斷和治療發展
  • 基因工程
    • 動物基因工程
    • 細胞株工程
    • 植物性因工程

第 9 章 CRISPR 基因編輯市場：依最終用途

  • 學術研究所
  • 製藥和生物技術公司

第10章 美洲CRISPR基因編輯市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章 亞太地區CRISPR基因編輯市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章 歐洲、中東和非洲的CRISPR基因編輯市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Synthego 和 SeQure Dx 合作為基於 CRISPR 的療法開發人員提供全面的脫靶分析服務
    • CRISPR QC 在 A 輪資金籌措中籌集 1000 萬美元
    • 新興企業Tome 以 2.5 億美元的基因編輯交易收購 Replace TX
  • 戰略分析和建議

公司名單

  • Agilent Technologies, Inc.
  • AstraZeneca PLC
  • Beam Therapeutics Inc.
  • Bio-Rad Laboratories, Inc.
  • Caribou Biosciences, Inc.
  • Cellectis SA
  • CRISPR Therapeutics AG
  • Danaher Corporation
  • Editas Medicine, Inc.
  • F. Hoffmann-La Roche AG
  • GeneCopoeia, Inc.
  • GenScript Biotech Corporation
  • Horizon Discovery Group Ltd. by Revvity, Inc.
  • Inscripta, Inc.
  • Intellia Therapeutics, Inc.
  • Lonza Group Ltd.
  • Mammoth Biosciences, Inc.
  • Merck KGaA
  • New England Biolabs, Inc.
  • OriGene Technologies, Inc.
  • Prime Medicine, Inc.
  • Qiagen NV
  • Sherlock Biosciences, Inc.
  • Thermo Fisher Scientific Inc.
  • ToolGen, Inc.
Product Code: MRR-5C6F41F5AF91

The CRISPR Gene Editing Market was valued at USD 3.25 billion in 2023, expected to reach USD 3.77 billion in 2024, and is projected to grow at a CAGR of 16.81%, to USD 9.66 billion by 2030.

CRISPR gene editing is a transformative technology that allows precise alterations to genetic sequences, which is revolutionizing biotechnology and medicine. The scope of CRISPR extends from agriculture to pharmaceuticals, with the potential to address genetic disorders, enhance crop resistance, and contribute to biotechnological advancements. The necessity of CRISPR arises from its ability to precisely target and edit genetic codes, making it indispensable for genetic research and therapy development. Its applications include gene therapy, genetic disease modeling, drug discovery, and agricultural genetic modification. Key end-users are academic institutions, biotechnology firms, and pharmaceutical companies involved in genetic research and product development.

KEY MARKET STATISTICS
Base Year [2023] USD 3.25 billion
Estimated Year [2024] USD 3.77 billion
Forecast Year [2030] USD 9.66 billion
CAGR (%) 16.81%

Market insights reveal that the CRISPR market growth is influenced by factors such as increased funding for genetic and genomic research, technological advancements in CRISPR platforms, and rising prevalence of genetic disorders that necessitate innovative therapeutic approaches. Opportunities abound in expanding CRISPR applications in precision medicine, developing CRISPR-based diagnostics, and synthetic biology. Companies can capitalize on these opportunities by investing in research collaborations, strengthening intellectual property portfolios, and expanding application areas beyond current therapeutics.

However, market growth faces limitations due to ethical concerns, regulatory hurdles, and potential off-target effects associated with CRISPR modifications. The complexity of patent landscapes also poses challenges to market entrants. Ethical considerations demand careful scrutiny and dialogue to ensure public acceptance and regulatory compliance, while ongoing research aims to improve specificity and reduce unintended mutations in gene editing.

The best areas for innovation and research include enhancing CRISPR accuracy, developing delivery mechanisms for in vivo applications, and exploring epigenetic modifications. Furthermore, integrating CRISPR with artificial intelligence and big data analytics can provide deeper insights and efficiency in research. The nature of the market is dynamic and rapidly evolving, with significant interdisciplinary collaborations driving progress. For sustained growth, businesses should focus on addressing ethical concerns and regulatory pathways while maintaining a strong commitment to technological innovation and public engagement.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving CRISPR Gene Editing Market

The CRISPR Gene Editing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing need for new vaccines and treatments for genetic diseases
    • Increasing private and public investments in biotechnological and pharmaceutical sectors
    • Adoption of CRISPR gene editing in space investigation
  • Market Restraints
    • High cost of CRISPR therapies
  • Market Opportunities
    • Advancements and improvements in CRISPR gene editing
    • Potential use of CRISPR gene editing in the agriculture sector
  • Market Challenges
    • Technical challenges and ethical concerns associated with CRISPR gene editing

Porter's Five Forces: A Strategic Tool for Navigating the CRISPR Gene Editing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the CRISPR Gene Editing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the CRISPR Gene Editing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the CRISPR Gene Editing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the CRISPR Gene Editing Market

A detailed market share analysis in the CRISPR Gene Editing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the CRISPR Gene Editing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the CRISPR Gene Editing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the CRISPR Gene Editing Market

A strategic analysis of the CRISPR Gene Editing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the CRISPR Gene Editing Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., AstraZeneca PLC, Beam Therapeutics Inc., Bio-Rad Laboratories, Inc., Caribou Biosciences, Inc., Cellectis S.A., CRISPR Therapeutics AG, Danaher Corporation, Editas Medicine, Inc., F. Hoffmann-La Roche AG, GeneCopoeia, Inc., GenScript Biotech Corporation, Horizon Discovery Group Ltd. by Revvity, Inc., Inscripta, Inc., Intellia Therapeutics, Inc., Lonza Group Ltd., Mammoth Biosciences, Inc., Merck KGaA, New England Biolabs, Inc., OriGene Technologies, Inc., Prime Medicine, Inc., Qiagen NV, Sherlock Biosciences, Inc., Thermo Fisher Scientific Inc., and ToolGen, Inc..

Market Segmentation & Coverage

This research report categorizes the CRISPR Gene Editing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Offering, market is studied across Reagents & Consumables, Services, and Software & Systems.
  • Based on Technology, market is studied across Anti-CRISPR Proteins, CRISPR/Cas13, CRISPR/Cas9, and CRISPR/Cpf1 (Cas12a).
  • Based on Application, market is studied across Diagnostics & Therapy Development and Genetic Engineering. The Genetic Engineering is further studied across Animal Genetic Engineering, Cell Line Engineering, and Plant Genetic Engineering.
  • Based on End-use, market is studied across Academic & Research Institutes and Pharmaceutical & Biotechnology Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing need for new vaccines and treatments for genetic diseases
      • 5.1.1.2. Increasing private and public investments in biotechnological and pharmaceutical sectors
      • 5.1.1.3. Adoption of CRISPR gene editing in space investigation
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of CRISPR therapies
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements and improvements in CRISPR gene editing
      • 5.1.3.2. Potential use of CRISPR gene editing in the agriculture sector
    • 5.1.4. Challenges
      • 5.1.4.1. Technical challenges and ethical concerns associated with CRISPR gene editing
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Technology: Increasing preference for CRISPR/Cas13 in application that involves the RNA manipulation
    • 5.2.2. End-use: Growing significance of CRISPR gene editing in pharmaceutical and biotechnology firms for therapeutic development and drug discovery
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. CRISPR Gene Editing Market, by Offering

  • 6.1. Introduction
  • 6.2. Reagents & Consumables
  • 6.3. Services
  • 6.4. Software & Systems

7. CRISPR Gene Editing Market, by Technology

  • 7.1. Introduction
  • 7.2. Anti-CRISPR Proteins
  • 7.3. CRISPR/Cas13
  • 7.4. CRISPR/Cas9
  • 7.5. CRISPR/Cpf1 (Cas12a)

8. CRISPR Gene Editing Market, by Application

  • 8.1. Introduction
  • 8.2. Diagnostics & Therapy Development
  • 8.3. Genetic Engineering
    • 8.3.1. Animal Genetic Engineering
    • 8.3.2. Cell Line Engineering
    • 8.3.3. Plant Genetic Engineering

9. CRISPR Gene Editing Market, by End-use

  • 9.1. Introduction
  • 9.2. Academic & Research Institutes
  • 9.3. Pharmaceutical & Biotechnology Companies

10. Americas CRISPR Gene Editing Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific CRISPR Gene Editing Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa CRISPR Gene Editing Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Synthego and SeQure Dx Partner to Provide Comprehensive Off-Target Analysis Services for CRISPR-Based Therapeutics Developers
    • 13.3.2. CRISPR QC Raises USD 10 Million in Series A Financing Round
    • 13.3.3. Newcomer Tome Acquires Replace TX in USD 250 Million Gene Editing Deal
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Agilent Technologies, Inc.
  • 2. AstraZeneca PLC
  • 3. Beam Therapeutics Inc.
  • 4. Bio-Rad Laboratories, Inc.
  • 5. Caribou Biosciences, Inc.
  • 6. Cellectis S.A.
  • 7. CRISPR Therapeutics AG
  • 8. Danaher Corporation
  • 9. Editas Medicine, Inc.
  • 10. F. Hoffmann-La Roche AG
  • 11. GeneCopoeia, Inc.
  • 12. GenScript Biotech Corporation
  • 13. Horizon Discovery Group Ltd. by Revvity, Inc.
  • 14. Inscripta, Inc.
  • 15. Intellia Therapeutics, Inc.
  • 16. Lonza Group Ltd.
  • 17. Mammoth Biosciences, Inc.
  • 18. Merck KGaA
  • 19. New England Biolabs, Inc.
  • 20. OriGene Technologies, Inc.
  • 21. Prime Medicine, Inc.
  • 22. Qiagen NV
  • 23. Sherlock Biosciences, Inc.
  • 24. Thermo Fisher Scientific Inc.
  • 25. ToolGen, Inc.

LIST OF FIGURES

  • FIGURE 1. CRISPR GENE EDITING MARKET RESEARCH PROCESS
  • FIGURE 2. CRISPR GENE EDITING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CRISPR GENE EDITING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC CRISPR GENE EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC CRISPR GENE EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CRISPR GENE EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CRISPR GENE EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. CRISPR GENE EDITING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. CRISPR GENE EDITING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CRISPR GENE EDITING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CRISPR GENE EDITING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CRISPR GENE EDITING MARKET DYNAMICS
  • TABLE 7. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY SOFTWARE & SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY ANTI-CRISPR PROTEINS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY CRISPR/CAS13, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY CRISPR/CAS9, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY CRISPR/CPF1 (CAS12A), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY DIAGNOSTICS & THERAPY DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY ANIMAL GENETIC ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY CELL LINE ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY PLANT GENETIC ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC CRISPR GENE EDITING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 94. PHILIPPINES CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 99. SINGAPORE CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 104. SOUTH KOREA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 109. TAIWAN CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 114. THAILAND CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 119. VIETNAM CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA CRISPR GENE EDITING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 130. DENMARK CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 135. EGYPT CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 140. FINLAND CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 145. FRANCE CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 150. GERMANY CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 155. ISRAEL CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 160. ITALY CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 165. NETHERLANDS CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 170. NIGERIA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 175. NORWAY CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 180. POLAND CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 185. QATAR CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 190. RUSSIA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 195. SAUDI ARABIA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH AFRICA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 205. SPAIN CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 210. SWEDEN CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 215. SWITZERLAND CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 220. TURKEY CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED KINGDOM CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 235. CRISPR GENE EDITING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 236. CRISPR GENE EDITING MARKET, FPNV POSITIONING MATRIX, 2023